Effects of rapamycin on number activity and eNOS of endothelial progenitor cells from peripheral blood

被引:43
作者
Chen, TG [1 ]
Chen, JZ [1 ]
Wang, XX [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiovasc Dis, Hangzhou 310003, Zhejiang Provin, Peoples R China
关键词
D O I
10.1111/j.1365-2184.2006.00375.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aim of this investigation is to determine whether rapamycin treatment has any effect on endothelial progenitor cells (EPCs). Total mononuclear cells (MNCs) were isolated from peripheral blood by Ficoll density gradient centrifugation, and then the cells were plated on fibronectin-coated culture dishes. After 7 days in culture, attached cells were stimulated with rapamycin (in a series of final concentrations: 0.1, 1.0, 2.0 and 5.0 g/ml) for 6, 12, 24 and 48 h. EPCs were characterized as adherent cells, double positive for DiLDL uptake and lectin binding by direct fluorescence staining. EPC proliferation and migration were determined using the MTT assay and a modified version of the Boyden chamber assay, respectively. An EPC adhesion assay was performed by replating the cells on fibronectin-coated dishes; adherent cells were then counted. Tube formation activity was assayed by using a tube formation assay kit and endothelial nitric oxide synthase (eNOS) was assayed by Western blot analysis. Incubation of isolated human MNCs with rapamycin decreased the number of EPCs present; rapamycin also decreased EPCs proliferative, migratory, adhesive, tube formation capacity and eNOS production in a concentration- and time-dependent manner. Rapamycin was found to decrease the number, proliferative, migratory, adhesive and tube formation capacities of the EPCs, and also was found to decreases eNOS in the EPCs.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 25 条
  • [1] Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro
    Butzal, M
    Loges, S
    Schweizer, M
    Fischer, U
    Gehling, UM
    Hossfeld, DK
    Fiedler, W
    [J]. EXPERIMENTAL CELL RESEARCH, 2004, 300 (01) : 65 - 71
  • [2] Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood
    Chen, JZ
    Zhu, JH
    Wang, XX
    Zhu, JH
    Xie, XD
    Sun, J
    Shang, YP
    Guo, XG
    Dai, HM
    Hu, SJ
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 36 (02) : 233 - 239
  • [3] DUMONT FJ, 1990, J IMMUNOL, V144, P251
  • [4] Potent inhibitory effect of sirolimus on circulating vascular progenitor cells
    Fukuda, D
    Sata, M
    Tanaka, K
    Nagai, R
    [J]. CIRCULATION, 2005, 111 (07) : 926 - 931
  • [5] Gehling UM, 2000, BLOOD, V95, P3106
  • [6] Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
    Guba, M
    von Breitenbuch, P
    Steinbauer, M
    Koehl, G
    Flegel, S
    Hornung, M
    Bruns, CJ
    Zuelke, C
    Farkas, S
    Anthuber, M
    Jauch, KW
    Geissler, EK
    [J]. NATURE MEDICINE, 2002, 8 (02) : 128 - 135
  • [7] Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
    Hill, JM
    Zalos, G
    Halcox, JPJ
    Schenke, WH
    Waclawiw, MA
    Quyyumi, AA
    Finkel, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) : 593 - 600
  • [8] Ilan N, 1998, J CELL SCI, V111, P3621
  • [9] Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
    Kalka, C
    Masuda, H
    Takahashi, T
    Kalka-Moll, WM
    Silver, M
    Kearney, M
    Li, T
    Isner, JM
    Asahara, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3422 - 3427
  • [10] Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
    Kocher, AA
    Schuster, MD
    Szabolcs, MJ
    Takuma, S
    Burkhoff, D
    Wang, J
    Homma, S
    Edwards, NM
    Itescu, S
    [J]. NATURE MEDICINE, 2001, 7 (04) : 430 - 436